A Review of the Current Status of Clinical Management of COVID-19 in the Elderly

Med Sci Monit. 2021 Apr 9:27:e930278. doi: 10.12659/MSM.930278.

Abstract

The high infectivity and severity of SARS-CoV-2 infection (COVID-19), and our limited understanding of the biology of the novel coronavirus, as well as the lack of an effective treatment for COVID-19, have created a global pandemic. Those most likely to become seriously ill with COVID-19 are adults, especially the elderly and those who are already weak or sick. At present, a specific drug for treatment of COVID-19 has not been developed. This, combined with the typical coexistence of a variety of chronic diseases in elderly patients, makes treatment challenging at present. In addition, for elderly patients, COVID-19 isolation measures during the epidemic can easily lead to psychological problems. Thus, how to manage elderly patients has become a focus of social attention in the current circumstances. This article reviews the effects of COVID-19 and makes management suggestions for elderly patients during this epidemic period. In addition to the elderly, critically ill people are also highly susceptible to this novel coronavirus. For elderly COVID-19 patients, antiviral therapy, immune regulation, and even auxiliary respiratory therapy can be given after a comprehensive evaluation of the disease. With the approval and use of COVID-19 vaccines, it is reasonable to expect that we can conquer SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Aged
  • Aging / immunology
  • Antiviral Agents / therapeutic use*
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / immunology
  • COVID-19 / therapy*
  • COVID-19 Vaccines / administration & dosage
  • Chronic Disease / epidemiology*
  • Combined Modality Therapy / methods
  • Comorbidity
  • Critical Illness / epidemiology
  • Disease Susceptibility
  • Humans
  • Respiratory Therapy / methods*
  • Risk Factors
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • Severity of Illness Index

Substances

  • Antiviral Agents
  • COVID-19 Vaccines